Matches in Wikidata for { <http://www.wikidata.org/entity/Q72801696> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q72801696 description "article scientifique publié en 1994" @default.
- Q72801696 description "artículu científicu espublizáu n'ochobre de 1994" @default.
- Q72801696 description "im Oktober 1994 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72801696 description "scientific article published on 01 October 1994" @default.
- Q72801696 description "wetenschappelijk artikel" @default.
- Q72801696 description "наукова стаття, опублікована в жовтні 1994" @default.
- Q72801696 name "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 name "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 type Item @default.
- Q72801696 label "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 label "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 prefLabel "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 prefLabel "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 P1433 Q72801696-AC907C29-EC85-4DDB-ACAF-2942A7F60B4E @default.
- Q72801696 P1476 Q72801696-143AB3F7-2E46-490D-8B18-CC975530B091 @default.
- Q72801696 P2093 Q72801696-38F3E723-CF06-4E60-84C8-56432D5F109A @default.
- Q72801696 P2093 Q72801696-3C25480E-DD56-4B71-ACED-C3771D590A73 @default.
- Q72801696 P2093 Q72801696-573C418A-F8E6-4C4F-BEDF-ECC6FEA4C21F @default.
- Q72801696 P2093 Q72801696-65A319FA-55D4-4A3F-9A56-8CD2945E0724 @default.
- Q72801696 P2093 Q72801696-778CE4AF-03A1-43F9-894C-231828AA6408 @default.
- Q72801696 P2093 Q72801696-A888D012-F4D0-434B-A2B0-AFBB8C6D2F35 @default.
- Q72801696 P304 Q72801696-D2CAF5E8-6809-40B4-85A6-433A70443815 @default.
- Q72801696 P31 Q72801696-7CA300AD-F18C-49FB-89D7-67D3F164B438 @default.
- Q72801696 P356 Q72801696-736D8EFA-48F0-46A2-8FC5-87F0A6298EE9 @default.
- Q72801696 P433 Q72801696-C8D0F2CB-A685-4C72-85DF-472B53ACABC1 @default.
- Q72801696 P478 Q72801696-339AF8C6-75BE-4105-BF38-7773D7991CE8 @default.
- Q72801696 P50 Q72801696-F84EA787-44D0-403D-BD45-958D7A63C227 @default.
- Q72801696 P577 Q72801696-B806E3B5-4922-473C-A0D9-20F6D83082FB @default.
- Q72801696 P698 Q72801696-26C3F38E-D872-4F8B-B5D6-EDC164D4F55E @default.
- Q72801696 P921 Q72801696-393C6565-518A-4B42-9A2E-A77F82D029C0 @default.
- Q72801696 P921 Q72801696-9A01FC52-95AE-4241-B8B5-575A6F1D29A3 @default.
- Q72801696 P921 Q72801696-BC721A57-E49A-48BD-BD99-4A895AF12B23 @default.
- Q72801696 P921 Q72801696-F79BFB28-4720-446F-AA6B-D06D50AFCE27 @default.
- Q72801696 P356 GYNO.1994.1245 @default.
- Q72801696 P698 7959265 @default.
- Q72801696 P1433 Q5625182 @default.
- Q72801696 P1476 "Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma" @default.
- Q72801696 P2093 "Baker VV" @default.
- Q72801696 P2093 "Burke TW" @default.
- Q72801696 P2093 "Gershenson DM" @default.
- Q72801696 P2093 "Levenback C" @default.
- Q72801696 P2093 "Morris M" @default.
- Q72801696 P2093 "Stringer CA" @default.
- Q72801696 P304 "47-50" @default.
- Q72801696 P31 Q13442814 @default.
- Q72801696 P356 "10.1006/GYNO.1994.1245" @default.
- Q72801696 P433 "1" @default.
- Q72801696 P478 "55" @default.
- Q72801696 P50 Q63468476 @default.
- Q72801696 P577 "1994-10-01T00:00:00Z" @default.
- Q72801696 P698 "7959265" @default.
- Q72801696 P921 Q18555222 @default.
- Q72801696 P921 Q18936 @default.
- Q72801696 P921 Q412415 @default.
- Q72801696 P921 Q974135 @default.